CRAIF
Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for many cancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis.
CRAIF
Industry:
Artificial Intelligence Health Care Health Diagnostics Machine Learning Medical
Founded:
2018-05-22
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.craif.com
Total Employee:
11+
Status:
Active
Total Funding:
11.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Euro
Current Advisors List
Board_member
Current Employees Featured
Onose Ryuichi Representative Director,CEO & Co-founder @ Craif
Representative Director,CEO & Co-founder
2018-05-01
Takeshita Daiki CSO & Co-founder @ Craif
CSO & Co-founder
Founder
Investors List
Global Brain Corporation
Global Brain Corporation investment in Series B - Craif
Saisei Ventures
Saisei Ventures investment in Series B - Craif
Aflac Global Ventures
Aflac Global Ventures investment in Series A - Craif
ANRI
ANRI investment in Series A - Craif
Daiwa Corporate Investment
Daiwa Corporate Investment investment in Series A - Craif
FF APAC Scout
FF APAC Scout investment in Series A - Craif
Mori Trust
Mori Trust investment in Series A - Craif
Japan Science and Technology Agency
Japan Science and Technology Agency investment in Seed Round - Craif
NEDO
NEDO investment in Seed Round - Craif
ANRI
ANRI investment in Seed Round - Craif
Official Site Inspections
http://www.craif.com
- Host name: www50.conoha.ne.jp
- IP address: 150.95.219.90
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Craif"
Craif - Crunchbase Company Profile & Funding
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology. ... Products. Resources. Pricing. Resources. Log In. Organization. Craif . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Craif is a biotechnology ...See details»
ABOUT US – Craif inc.
WE ENSURE LIFELONG HEALTH FOR EVERYONE. Our mission is to detect cancer in the earliest stages using urine. Our core technology is the unique nanowire device capable of extracting 99% of exosomes, known for their deep relationship with diseases, making them promising biomarkers.See details»
Craif Inc. – Craifの使命は、尿検査による「痛みのない …
Craifの使命は、尿検査による「痛みのない高精度ながん早期発見」の実現です。Craifは人々ががんで命を落とすことのない、新たな社会の構築を目指します。See details»
Craif Company Profile 2025: Valuation, Funding
Craif General Information Description. Provider of exosome-based liquid biopsy tests intended to provide accurate and unpainful early cancer detection. The company's bio-platform encapsulates ribonucleic acid, a non-coding …See details»
Craif – an Unreasonable company
Craif is a molecular diagnostics company harnessing the power of miRNA and machine learning to develop an early detection classifier. Our proprietary miRNA platform and sampling technology enable the capture of low-expression …See details»
Craif - Ownership and Business Overview - Mergr
Mar 4, 2024 Craif develops and sells test kits that can easily and highly sensitively detect the risks of seven types of cancer, including pancreatic and lung cancer, as early as cancer stage 1. These kits comprehensively and efficiently capture and measure small microRNA molecules called miRNA2 in urine, which are generally difficult to detect.See details»
Craif Inc. - LinkedIn
Craif Inc. | 190 followers on LinkedIn. ... Kristine Mechem Serial Entrepreneur with IPO experience, seasoned commercial and strategic leadership including CCDO, VP Marketing, VP Sales, multiple ...See details»
CRAIF INC. Company Profile | BUNKYO-KU, TOKYO, Japan
Find company research, competitor information, contact details & financial data for CRAIF INC. of BUNKYO-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
Craif Inc. Asset Profile | Preqin
Craif's primary product, MySignal, is a cancer risk assessment test designed for early detection and prevention. The company plans to use the funds raised in March 2024 for research and development of testing services, enhancing clinical research, and expanding its workforce.See details»
Craif - Crunchbase
Craif develops a cancer diagnosis algorithm by combining the microRNA database with machine learning technology.See details»
Craif - Overview, News & Similar companies | ZoomInfo.com
Craif Inc is a company that operates in the Research & Development industry. It employs 10to19 people and has 5Mto10M of revenue. The company is he adquartered in Yushima, Tokyo, Japan. Read more. Craif's Social Media. Is this data correct? View contact profiles from Craif.See details»
LEADERSHIP – Craif inc.
Craifの使命は、尿検査による「痛みのない高精度ながん早期発見」の実現です。Craifは人々ががんで命を落とすことのない、新たな社会の構築を目指します。See details»
Craif - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial data. obfuscated. Unlock for free . Sep 29, 2020: Non Equity Assistance - Craif . 1: obfuscated. obfuscated — Sep 29, 2020: Non Equity Assistance - Craif . 1 ...See details»
Toyoda Gosei Invests in Craif, Inc., a Startup ... - Financial Post
Mar 4, 2024 1 Investment made in February 2024, through Toyoda Gosei’s Corporate Venture Capital Dept., an internal organization dedicated to these investments. 2 The amount and type of miRNA contained in urine differs depending on the type of cancer and its progression. This makes miRNA contribute to the detection of the cancer risk. Outline of Craif, Inc.See details»
Toyoda Gosei Invests in Craif
Mar 5, 2024 Toyoda Gosei Invests in Craif, Inc., a Startup Developing Urine Test Kits for Higher Possibility of the Early Detection of Cancer ... through Toyoda Gosei’s Corporate Venture Capital Dept., an internal organization dedicated to these investments. 2 The amount and type of miRNA contained in urine differs depending on the type of cancer and its ...See details»
Craif - Contacts, Employees, Board Members, Advisors & Alumni
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. Craif . Connect to CRM . Save . Summary.See details»
CAREER – Craif inc.
I believe Craif is a great place where they can truly devote themselves to research. Of course, in addition to research activities, each of us can work on business strategy, recruitment, management, budget allocation, etcetera, as a representative of the division. It is the perfect environment for those who want to experience growth in a ...See details»
Craif Raises 1B Yen from Keisuke Honda’s X&KSK in Series C1 …
Dec 25, 2024 Craif, a startup developing ultra-early cancer detection technology using microRNA and AI, announced on December 23 that it has secured 1 billion yen from X&KSK, led by soccer star Keisuke Honda, in the first close of its Series C round. This marks X&KSK’s largest investment to date and follows the funding from Toyoda Gosei (TSE: 7282) and Toyota …See details»
Craig Group Expands Leadership Team and Launches Innovative …
1 day ago Craig Group, a leading revenue growth advisory firm serving middle-market, private-equity-backed companies, announced the addition of two new partners and the launch of Conduit™, a revolutionary ...See details»
Craif、シリーズCラウンド(1stクローズ)で10億円の資金調達を実 …
Dec 23, 2024 尿がん検査「マイシグナル ® 」を提供するCraif株式会社（本社：東京都文京区、CEO：小野瀨 隆一、以下Craif）は、シリーズCラウンドの1stクローズとして、本田圭佑氏が率いるX&KSKをリード投資家に迎えた資金調達を実施しました。 X&KSKは単独で10億円を出資し、これは同ファンドにとって過去 ...See details»